Bladder Cancer Progression & Immune Microenvironment
OPPORTUNITYOncology teams lacked a reliable way to stratify bladder cancer patients by progression risk and immune response.
WHAT I BUILTAn end-to-end genomic analysis pipeline — expression profiling, pathway enrichment, and immune deconvolution — across 233 patient samples.
IMPACTSurfaced candidate biomarkers for patient stratification, the kind of signal a diagnostics product would build on.


